Publications  
 

Research Overview
Publications

 

 

Thu Nguyen, Ellen M Menocal, Jens Harborth & Johannes H Fruehauf

RNAi therapeutics: An update on delivery. Current Opinion in Molecular Therapeutics 10(2):158-167. 2008 April

Click Here for PDF

 

Shuanglin Xiang, Johannes Fruehauf and Chiang J. Li.

Short hairpin RNA–expressing bacteria elicit RNA interference in mammals. Nat Biotechnol. 2006 Jun;24(6):697-702. Epub 2006 May 14.

Click Here for PDF

 

Charles X. Li, Amy Parker, Ellen Menocal, Shuanglin Xiang, Laura Borodyansky, and Johannes H. Fruehauf
Delivery of RNA interference. Cell Cycle 5(18): 2103-2109, 2006 September 15

Click Here for PDF

 

Denis E. Corpet and Fabrice Pierre

How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men

European Journal of Cancer 41 (2005): 1911–1922, 15 June 2005

 

Claribel P. Taylor and J. Thomas LaMont

Genetically Engineered Probiotics: A New Twist on an Old Remedy. Gastroenterology 128(5):1509-1512, 2005 May 

Premlata Shankar, N. Manjunath, and Judy Lieberman
The Prospect of Silencing Disease Using RNA Interference. JAMA 293(11):1367-1373. 2005 March 15

Rajnish A. Gupta, Dingzhi Wang, Sharada Katkuri, Haibin Wang, Sudhansu K. Dey, and Raymond N. DuBois
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-δ accelerates intestinal adenoma growth. Nature Medicine 10(3): 245-247, 2004 March

John M Pawelek, K Brooks Low, and David Bermudes

Bacteria as tumour-targeting vectors. The Lancet Oncology (4):548-556, 2003 September

John Nemunaitis, Casey Cunningham, Neil Senzer, Joseph Kuhn, Jennifer Cramm, Craig Litz, Robert Cavagnolo, Ann Cahill, Caroline Clairmont, and Mario Sznol 
Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Cancer Gene Therapy 10: 737–744. 2003 February 01

John F. Toso, Vee J. Gill, Patrick Hwu, Francesco M. Marincola, Nicholas P. Restifo, Douglas J. Schwartzentruber, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Frida Stock, Linda J. Freezer, Kathleen E. Morton, Claudia Seipp, Leah Haworth, Sharon Mavroukakis, Donald White, Susan MacDonald, John Mao, Mario Sznol, and Steven A. Rosenberg 
Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma.  Journal of Clinical Oncology, 20(1): 142-152, 2002 January 01

Mario Sznol, Stanley L. Lin, David Bermudes, Li-mou Zheng, and Ivan King
Use of preferentially replicating bacteria for the treatment of cancer. The Journal of Clinical Investigation 105(8):1027-1030, 2000 April 

 


 
 
o